Pfizer reports good results against severe COVID-19 for its antiviral pill

Nov 05, 2021

In a trial, the oral drug Paxlovid reduced the risk of hospitalization or death by 89%.

Stephanie Soucheray | News Reporter | CIDRAP NewsNov 05, 2021In a trial, the oral drug Paxlovid reduced the risk of hospitalization or death by 89%.Read More

Leave a Reply

Your email address will not be published.